Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
Wall Street and Cancer Care
AVBCC 2020 Summit
Conference Correspondent
— December 11, 2020
In this session, a panel of experts share the Wall Street perspective on the opportunities and challenges ahead for cancer drug developers and healthcare providers.
Read Article
Cancer Care: The Real-World Economics and Value Realities
AVBCC 2020 Summit
Conference Correspondent
— December 9, 2020
Healthcare continues to adapt to the economic impact of the COVID-19 pandemic. In this session, industry experts discuss the underlying trends and economic realities of cancer care in the United States and global markets.
Read Article
Oncology Drug Supply Chain Channels and the Move to Value
AVBCC 2020 Summit
Conference Correspondent
— December 8, 2020
The increased complexity of new oncology drugs and the accelerated rate of their approval has led to greater demands from stakeholders across the cancer care continuum. In this session, panelists discuss oncology drug supply chain channels and how they are incorporated in the move to value-based care.
Read Article
Recognizing Better Outcomes in Stem-Cell Transplantation
AVBCC 2020 Summit
Conference Correspondent
— December 4, 2020
Numerous new innovations in stem-cell transplantation are coming to the market. In this session, experts offer the clinician, manufacturer, and payer perspectives regarding these new therapies.
Read Article
OCM Government Programs and Impact on Cancer Care
AVBCC 2020 Summit
Conference Correspondent
— December 3, 2020
As one of the largest operational oncology value-based payment models, OCM has been a driving force in cancer
Read Article
Drug Benefit Reform and Cancer Care
AVBCC 2020 Summit
Conference Correspondent
— December 2, 2020
Cancer care is complex and expensive, making a one-size-fits-all approach to drug benefit designs and coverages an unfavorable solution for patients with cancer. In this session, panelists discuss drug benefit reforms and the intended and unintended consequences of the recommended provisions.
Read Article
Value-Based Contracting in the Pharma Space: Opportunities for Innovation and Overcoming Obstacles
AVBCC 2020 Summit
Conference Correspondent
— December 1, 2020
With multiple stakeholders playing a key role in value-based contracting, the pharmaceutical industry faces many obstacles. In this session, experts discuss these obstacles and the strategies for overcoming them.
Read Article
340B Program Developments
AVBCC 2020 Summit
Conference Correspondent
— November 30, 2020
340B is a discount program for low-income areas that increases resources and allows for patient expansion. In this session, panelists discuss the accuracy of pricing, the current state of the program, and future developments.
Read Article
The Clinical Utility of Genomic Testing in Cancer Care
AVBCC 2020 Summit
Conference Correspondent
— November 24, 2020
In this session, industry leaders discuss defining clinical utility for genomic testing and make recommendations to ensure appropriate implementation in cancer care.
Read Article
Patient Engagement and Cancer Care
AVBCC 2020 Summit
Conference Correspondent
— November 23, 2020
Technology can enhance the patient engagement experience, creating a willingness among patients to receive advice and counseling virtually. In this session, experts discuss the challenges of engaging patients and the future of technology in the healthcare system as it relates to cancer care.
Read Article
Page 4 of 44
1
2
3
4
5
6
7
8
9
10
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma